EU To Donate Mpox Vaccines To Africa As Public Health Emergency Is Declared

The Africa CDC says the donation of more than 215,000 doses of mpox vaccine is a “crucial step” in tackling the latest outbreak.

Syringe with vaccine with map of Africa background
mpox vaccines are to be donated to Africa. • Source: Shutterstock

The EU is to procure 175,420 doses of Bavarian Nordic A/S’s mpox vaccine, MVA-BN, and donate them to Africa where they will distributed to countries affected by the latest outbreak of the disease.

More from Middle East & Africa

Africa Partners With PIC/S To Elevate GMP Standards And Accelerate AMA’s Rollout

 

Efforts have stepped up to enhance Africa’s capacity to meet international good manufacturing practice standards, empower regulators across the continent, and drive sustainable growth in the pharmaceutical sector.

Japan Ships First Batch Of Mpox Vaccines To DRC

 
• By 

Japan ships the first batch of 50,000 mpox vaccine doses to DRC after training local healthcare providers dealing with the persistent outbreak.

African Regulators Reach Big WHO Milestones

 

Egypt is the first African country to win a WHO maturity level 3 benchmarking rating for medicines and vaccines that are locally produced and imported.

EU HTA Regulation: Views Wanted On Draft Rules On Joint Scientific Consultations

 

A newly published draft implementing act sets out the procedural rules for the joint scientific consultations that are foreseen by the EU’s Health Technology Assessment Regulation.

More from Pink Sheet

Pink Sheet Podcast: Understanding The Impact Of The Latest HHS Layoffs On The US FDA

 

Pink Sheet reporter and editors discuss how staff may not be the only thing the FDA could lose with the latest layoffs announced by the Health and Human Services Department.

EMA Recommends EU Approval For Averoa’s Xoanacyl And Four Other Drugs

 

The European Medicines Agency has recommended five drugs for EU-wide approval , including Averoa’s Xoanacyl for concomitant hyperphosphatemia. Two companies have withdrawn their marketing authorization applications.

European Regulator Deals Blow For Lilly’s Alzheimer’s Drug Kisunla

 

Eli Lilly’ will request a re-examination after the European Medicines Agency declined to recommend its Alzheimer’s disease drug Kisunla for EU approval.